On March 11, 2026, a delegation from the Shenzhen Nanshan Medical Group Headquarters, including Chief President Zhang Fei, Deputy Chief Presidents Mo Beirong and Huang Cao,  Deputy Director Zhu Ronghui from the Community Management Department, Deputy Director Xu Quancheng from the Quality Department, and Director Li Chengliang, visited Shenzhen Cell Valley for collaboration discussions. The exchange focused on topics such as clinical translation of cell and gene therapy (CGT) technologies, collaborative innovation among industry, academia, research, and healthcare, and industrial cooperation under policy compliance. Shenzhen Cell Valley's Chairman and General Manager, Professor Shi Yuan, Administrative Director Wei Zheng, and Chairman's Assistant Fu Yuchen, 、 warmly received the delegation.

Chairman's Assistant Fu Yuchen accompanied the delegation on a tour of Shenzhen Cell Valley's smart exhibition hall, R&D laboratories, and GMP production facilities. They observed the standardized R&D and production environment, the full-process quality control system, and gained an initial understanding of the core technological R&D and industrial operation achievements in cell therapy. 

During the symposium, Professor Shi Yuan, Chairman of Shenzhen Cell Valley, provided a detailed introduction to the company's development journey, core technology pipeline, R&D strategic layout, latest progress in Shenzhen-Hong Kong collaboration, and innovative explorations in the field of cell therapy. He emphasized the development philosophy of " prioritizing clinical needs to bring cutting-edge technologies to benefit the public ", development opportunities under new policies, models for hospital-enterprise collaboration, and innovative pathways for Shenzhen-Hong Kong medical integration. He explicitly stated that Shenzhen Cell Valley is willing to collaborate with the Nanshan Medical Group Headquarters, leveraging their respective strengths to tackle technical challenges in cell therapy, accelerate the translation of research outcomes, and contribute to elevating regional healthcare standards.

Chief President Zhang Fei noted in his remarks that as a core entity for regional healthcare services, the Nanshan Medical Group has always prioritized introducing advanced medical technologies, focusing on chronic disease management and intervention, and enhancing clinical service capabilities. He highlighted the strong complementarity between Shenzhen Cell Valley's technological strengths and industrial capabilities in CGT and the Nanshan Medical Group's clinical resources and service network. He expressed hope that this exchange would serve as a starting point for establishing a regular collaboration mechanism, jointly exploring the full-chain collaborative innovation model of " basic research - technology translation - clinical application " to bring more cutting-edge biotechnological benefits to local residents.

This visit and exchange not only enhanced mutual understanding between both parties but also laid a solid foundation for in-depth collaboration in the future. Shenzhen Cell Valley will continue to leverage its technological and platform advantages, deepen its expertise in the field of cell and gene therapy, drive breakthroughs and upgrades in the cell industry, and contribute to the innovative development of the biopharmaceutical industry.

 Headquarters of Shenzhen Nanshan Medical Group

 Shenzhen Nanshan Medical Group is a public institution under the leadership of the Health Work Committee of Shenzhen Nanshan District Committee and established by the Health Bureau of Shenzhen Nanshan District. The medical group operates under a 1+C+N model. "1" refers to the Headquarters of Shenzhen Nanshan Medical Group (including 81 subordinate community health service institutions, hereafter the same), "C" represents member units, which are district-owned public medical and health institutions, including Huazhong University of Science and Technology Union Shenzhen Hospital, Shekou People's Hospital, Southern University of Science and Technology Hospital, Nanshan District Maternity and Child Healthcare Hospital, Nanshan District Center for Disease Control and Prevention, and Nanshan District Chronic Disease Prevention and Treatment Hospital; "N" denotes other medical and health institutions in the district. The medical group aims to adopt a problem-oriented approach, with the direction of "building high ground and strengthening grassroots," by guiding the al of medical resources to the community level to enhance the service capacity of community health centers, promote tiered diagnosis and treatment, and facilitate two-way referrals. Through the implementation of integrated and refined management, it seeks to improve the service quality and standardization of community health centers. By consolidating medical and health resources, it aims to maximize the sharing and utilization efficiency of these resources. Through the establishment of a modern hospital management system, it ensures the public welfare nature of public hospitals and fosters their development. With 3-5 years of relentless effort, the group aspires to build a high-quality grassroots medical and health professional team, create a standardized Nanshan community health service quality brand, and establish a first-class integrated high-quality medical service system.